Literature DB >> 32493506

Correction to: Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial.

B Joseph Elmunzer1, Jose Serrano2, Amitabh Chak3, Steven A Edmundowicz4, Georgios I Papachristou5, James M Scheiman6, Vikesh K Singh7, Shyam Varadarajulu8, John J Vargo9, Field F Willingham10, Todd H Baron11, Gregory A Coté12, Joseph Romagnuolo13, April Wood-Williams12, Emily K Depue12, Rebecca L Spitzer12, Cathie Spino14, Lydia D Foster15, Valerie Durkalski15.   

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Entities:  

Year:  2020        PMID： 32493506      PMCID： PMC7271536          DOI： 10.1186/s13063-020-04458-0

Source DB:  PubMed          Journal:  Trials        ISSN： 1745-6215            Impact factor:   2.279


  1 in total

1.  Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial.

Authors:  B Joseph Elmunzer; Jose Serrano; Amitabh Chak; Steven A Edmundowicz; Georgios I Papachristou; James M Scheiman; Vikesh K Singh; Shyam Varadurajulu; John J Vargo; Field F Willingham; Todd H Baron; Gregory A Coté; Joseph Romagnuolo; April Wood-Williams; Emily K Depue; Rebecca L Spitzer; Cathie Spino; Lydia D Foster; Valerie Durkalski
Journal:  Trials       Date:  2016-03-03       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.